Artificial intelligence can detect early signs of glaucoma, study shows

Artificial intelligence systems can use machine learning to  identify early signs of glaucoma, a study published in Ophthalmology found. 

Advertisement

The study was led by Siamak Yousefi, PhD, an assistant professor from University of Tennessee’s department of ophthalmology in Memphis.  

Researchers used an AI visual field analyzer that looked for vision loss patterns typically indicating glaucoma in 176 participants and compared results to an assessment by a traditional ocular hypertension treatment study-certified visual field reader over the course of 16 years. 

According to the study’s researchers, results showed that AI-based automated machine learning systems can identify early signs of visual field loss and recognize early signs of glaucoma in participants with the same accuracy as ophthalmology experts.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in Ophthalmology

  • East Lansing-based Michigan Surgical Center has disclosed a data breach that may have exposed personal information, according to a July…

  • Cincinnati-based MidWest Eye Center welcomed Alec Bradley, MD, an ophthalmologist who specializes in premium cataract surgery, refractive surgery, microinvasive glaucoma…

Advertisement

Comments are closed.